Karuna Therapeutics, Inc. Recorded Big Gain
Mon, Aug 08, 2022 at 07:20 PM
Karuna Therapeutics, Inc. (KRTX:NASDAQ) soared at $241.19, a gain of 71.8%. On Mon, Aug 08, 2022, KRTX:NASDAQ touched a New 2-Week High of $241.19. The stock appeared on our News Catalysts scanner on Mon, Aug 08, 2022 at 07:06 PM in the 'BIOTECH' category. From Mon, Jul 25, 2022, the stock recorded 80.00% Up Days and 63.64% Green Days
About Karuna Therapeutics, Inc. (KRTX:NASDAQ)
Karuna Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical need. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.
Top 10 Gainers:
- Helbiz Inc. (HLBZ:NASDAQ), 114.64%
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 102.66%
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 71.84%
- Senmiao Technology Limited (AIHS:NASDAQ), 68.14%
- Bonso Electronics International Inc. (BNSO:NASDAQ), 64.85%
- Heart Test Laboratories, Inc. (HSCS:NASDAQ), 55.66%
- CinCor Pharma Inc. (CINC:NASDAQ), 49.25%
- SOS Limited American Depositary Shares (SOS:NYSE), 42.8%
- Surgalign Holdings Inc. (SRGA:NASDAQ), 42.25%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 40.83%